New drug cocktail aims to shrink Hard-to-Treat sarcomas
NCT ID NCT07156643
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tests a combination of drugs (anlotinib, bempegaldesleukin) plus standard chemoradiotherapy for people with advanced soft tissue sarcoma that cannot be removed by surgery. The goal is to see if this treatment can shrink tumors and control the disease. About 46 adults aged 18-80 will take part. The approach is exploratory, meaning it's not yet proven to work better than current options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jiangsu Province Hospital
Nanjing, China
Contact
Conditions
Explore the condition pages connected to this study.